|
GUARANTOR AND NONGUARANTOR FINANCIAL INFORMATION (Details 3) (Details) (USD $)
In Thousands, unless otherwise specified
|
12 Months Ended |
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
| Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
| Net cash provided by operating activities attributable to continuing operations |
$ 410,961 |
$ 354,527 |
$ 372,386 |
| Acquisitions, net of cash acquired |
(40,690) |
(411,035) |
(278,469) |
| Capital expenditures |
(80,311) |
(51,201) |
(39,954) |
| Proceeds from maturities and sales of marketable debt securities |
12,502 |
195,501 |
584,935 |
| Proceeds from sales of long-term investments |
69,968 |
14,194 |
15,214 |
| Purchases of long-term investments |
(51,080) |
(36,094) |
(90,245) |
| Other, net |
9,594 |
(9,501) |
(12,697) |
| Net cash used in investing activities attributable to continuing operations |
(80,017) |
(352,088) |
(25,186) |
| Proceeds from issuance of long-term debt |
500,000 |
500,000 |
|
| Principal payments on long-term debt |
(15,844) |
0 |
0 |
| Purchase of treasury stock |
(264,214) |
(691,830) |
(507,765) |
| Dividends |
(79,189) |
(68,163) |
(10,668) |
| Issuance of common stock, net of withholding taxes |
(5,077) |
262,841 |
132,785 |
| Excess tax benefits from stock-based awards |
32,891 |
57,101 |
22,166 |
| Purchase of noncontrolling Interests |
(67,947) |
(4,891) |
(3,843) |
| Purchases of marketable debt securities |
|
(53,952) |
(203,970) |
| Funds transferred to escrow for Meetic tender offer |
(71,512) |
0 |
0 |
| Debt issuance Costs |
(7,399) |
(11,001) |
0 |
| Other, net |
(3,787) |
244 |
(4,908) |
| Net cash provided by (used in) financing activities attributable to continuing operations |
17,922 |
44,301 |
(372,233) |
| Total cash used in continuing operations |
348,866 |
46,740 |
(25,033) |
| Total cash used in discontinued operations |
(1,877) |
(3,472) |
(8,417) |
| Effect of exchange rate changes on cash and cash equivalents |
3,478 |
2,556 |
(4,496) |
| Net increase (decrease) in cash and cash equivalents |
350,467 |
45,824 |
(37,946) |
| Cash and cash equivalents at beginning of period |
749,977 |
704,153 |
742,099 |
| Cash and cash equivalents at end of period |
1,100,444 |
749,977 |
704,153 |
|
IAC
|
|
|
|
| Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
| Net cash provided by operating activities attributable to continuing operations |
(95,081) |
(116,353) |
(75,300) |
| Acquisitions, net of cash acquired |
0 |
(35,159) |
0 |
| Capital expenditures |
(1,387) |
(3,969) |
(798) |
| Proceeds from maturities and sales of marketable debt securities |
12,502 |
195,501 |
267,635 |
| Proceeds from sales of long-term investments |
7,839 |
14,194 |
10,214 |
| Purchases of long-term investments |
(17,814) |
(27,187) |
(35,263) |
| Other, net |
0 |
(351) |
0 |
| Net cash used in investing activities attributable to continuing operations |
1,140 |
89,077 |
167,548 |
| Proceeds from issuance of long-term debt |
500,000 |
500,000 |
|
| Principal payments on long-term debt |
(15,844) |
|
|
| Purchase of treasury stock |
(264,214) |
(691,830) |
(507,765) |
| Dividends |
(79,189) |
(68,163) |
(10,668) |
| Issuance of common stock, net of withholding taxes |
(5,077) |
262,841 |
132,785 |
| Excess tax benefits from stock-based awards |
32,081 |
52,209 |
22,166 |
| Purchase of noncontrolling Interests |
0 |
(1,936) |
(3,843) |
| Purchases of marketable debt securities |
|
(53,952) |
(74,240) |
| Funds transferred to escrow for Meetic tender offer |
0 |
|
|
| Debt issuance Costs |
(7,399) |
(11,001) |
|
| Intercompany |
216,359 |
(55,020) |
824,194 |
| Other, net |
|
|
|
| Net cash provided by (used in) financing activities attributable to continuing operations |
376,717 |
(12,900) |
456,869 |
| Total cash used in continuing operations |
282,776 |
(40,176) |
549,117 |
| Total cash used in discontinued operations |
(1,829) |
(3,971) |
(7,166) |
| Effect of exchange rate changes on cash and cash equivalents |
0 |
0 |
3,271 |
| Net increase (decrease) in cash and cash equivalents |
280,947 |
(44,147) |
545,222 |
| Cash and cash equivalents at beginning of period |
501,075 |
545,222 |
0 |
| Cash and cash equivalents at end of period |
782,022 |
501,075 |
545,222 |
|
Guarantor Subsidiaries
|
|
|
|
| Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
| Net cash provided by operating activities attributable to continuing operations |
537,116 |
453,692 |
367,719 |
| Acquisitions, net of cash acquired |
(6,638) |
(341,963) |
(80,998) |
| Capital expenditures |
(63,931) |
(29,550) |
(29,542) |
| Proceeds from maturities and sales of marketable debt securities |
0 |
0 |
0 |
| Proceeds from sales of long-term investments |
50,850 |
0 |
0 |
| Purchases of long-term investments |
0 |
(724) |
(51,008) |
| Other, net |
(1,725) |
117 |
1,886 |
| Net cash used in investing activities attributable to continuing operations |
(21,444) |
(372,120) |
(159,662) |
| Proceeds from issuance of long-term debt |
|
|
|
| Principal payments on long-term debt |
0 |
|
|
| Purchase of treasury stock |
|
|
|
| Dividends |
|
|
|
| Issuance of common stock, net of withholding taxes |
|
|
|
| Excess tax benefits from stock-based awards |
|
4,892 |
|
| Purchase of noncontrolling Interests |
0 |
0 |
0 |
| Purchases of marketable debt securities |
|
0 |
0 |
| Funds transferred to escrow for Meetic tender offer |
0 |
|
|
| Debt issuance Costs |
0 |
0 |
|
| Intercompany |
(514,464) |
(86,446) |
(207,950) |
| Other, net |
(1,225) |
|
(249) |
| Net cash provided by (used in) financing activities attributable to continuing operations |
(515,689) |
(81,554) |
(208,199) |
| Total cash used in continuing operations |
(17) |
18 |
(142) |
| Total cash used in discontinued operations |
|
|
|
| Effect of exchange rate changes on cash and cash equivalents |
17 |
(18) |
142 |
| Net increase (decrease) in cash and cash equivalents |
0 |
0 |
0 |
| Cash and cash equivalents at beginning of period |
0 |
0 |
0 |
| Cash and cash equivalents at end of period |
0 |
0 |
0 |
|
Non-Guarantor Subsidiaries
|
|
|
|
| Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
| Net cash provided by operating activities attributable to continuing operations |
(31,074) |
17,188 |
79,967 |
| Acquisitions, net of cash acquired |
(34,052) |
(33,913) |
(197,471) |
| Capital expenditures |
(14,993) |
(17,682) |
(9,614) |
| Proceeds from maturities and sales of marketable debt securities |
0 |
0 |
317,300 |
| Proceeds from sales of long-term investments |
11,279 |
0 |
5,000 |
| Purchases of long-term investments |
(33,266) |
(8,183) |
(3,974) |
| Other, net |
11,319 |
(9,267) |
(14,583) |
| Net cash used in investing activities attributable to continuing operations |
(59,713) |
(69,045) |
(33,072) |
| Proceeds from issuance of long-term debt |
|
|
|
| Principal payments on long-term debt |
0 |
|
|
| Purchase of treasury stock |
|
|
|
| Dividends |
|
|
|
| Issuance of common stock, net of withholding taxes |
|
|
|
| Excess tax benefits from stock-based awards |
810 |
|
|
| Purchase of noncontrolling Interests |
(67,947) |
(2,955) |
0 |
| Purchases of marketable debt securities |
|
0 |
(129,730) |
| Funds transferred to escrow for Meetic tender offer |
(71,512) |
|
|
| Debt issuance Costs |
0 |
0 |
|
| Intercompany |
298,105 |
141,466 |
(616,244) |
| Other, net |
(2,562) |
244 |
(4,659) |
| Net cash provided by (used in) financing activities attributable to continuing operations |
156,894 |
138,755 |
(620,903) |
| Total cash used in continuing operations |
66,107 |
86,898 |
(574,008) |
| Total cash used in discontinued operations |
(48) |
499 |
(1,251) |
| Effect of exchange rate changes on cash and cash equivalents |
3,461 |
2,574 |
(7,909) |
| Net increase (decrease) in cash and cash equivalents |
69,520 |
89,971 |
(583,168) |
| Cash and cash equivalents at beginning of period |
248,902 |
158,931 |
742,099 |
| Cash and cash equivalents at end of period |
318,422 |
248,902 |
158,931 |
|
Total Eliminations
|
|
|
|
| Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
| Net cash provided by operating activities attributable to continuing operations |
0 |
0 |
0 |
| Acquisitions, net of cash acquired |
0 |
0 |
0 |
| Capital expenditures |
0 |
0 |
0 |
| Proceeds from maturities and sales of marketable debt securities |
0 |
0 |
0 |
| Proceeds from sales of long-term investments |
0 |
0 |
0 |
| Purchases of long-term investments |
0 |
0 |
0 |
| Other, net |
0 |
0 |
0 |
| Net cash used in investing activities attributable to continuing operations |
0 |
0 |
0 |
| Proceeds from issuance of long-term debt |
0 |
0 |
|
| Principal payments on long-term debt |
0 |
|
|
| Purchase of treasury stock |
0 |
0 |
0 |
| Dividends |
0 |
0 |
0 |
| Issuance of common stock, net of withholding taxes |
0 |
0 |
0 |
| Excess tax benefits from stock-based awards |
0 |
0 |
0 |
| Purchase of noncontrolling Interests |
0 |
0 |
0 |
| Purchases of marketable debt securities |
|
0 |
0 |
| Funds transferred to escrow for Meetic tender offer |
0 |
|
|
| Debt issuance Costs |
0 |
0 |
|
| Intercompany |
0 |
0 |
0 |
| Other, net |
0 |
0 |
0 |
| Net cash provided by (used in) financing activities attributable to continuing operations |
0 |
0 |
0 |
| Total cash used in continuing operations |
0 |
0 |
0 |
| Total cash used in discontinued operations |
0 |
0 |
0 |
| Effect of exchange rate changes on cash and cash equivalents |
0 |
0 |
0 |
| Net increase (decrease) in cash and cash equivalents |
0 |
0 |
0 |
| Cash and cash equivalents at beginning of period |
0 |
0 |
0 |
| Cash and cash equivalents at end of period |
0 |
0 |
0 |
|
IAC Consolidated
|
|
|
|
| Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
| Net cash provided by operating activities attributable to continuing operations |
410,961 |
354,527 |
372,386 |
| Acquisitions, net of cash acquired |
(40,690) |
(411,035) |
(278,469) |
| Capital expenditures |
(80,311) |
(51,201) |
(39,954) |
| Proceeds from maturities and sales of marketable debt securities |
12,502 |
195,501 |
584,935 |
| Proceeds from sales of long-term investments |
69,968 |
14,194 |
15,214 |
| Purchases of long-term investments |
(51,080) |
(36,094) |
(90,245) |
| Other, net |
9,594 |
(9,501) |
(12,697) |
| Net cash used in investing activities attributable to continuing operations |
(80,017) |
(352,088) |
(25,186) |
| Proceeds from issuance of long-term debt |
500,000 |
500,000 |
|
| Principal payments on long-term debt |
(15,844) |
|
|
| Purchase of treasury stock |
(264,214) |
(691,830) |
(507,765) |
| Dividends |
(79,189) |
(68,163) |
(10,668) |
| Issuance of common stock, net of withholding taxes |
(5,077) |
262,841 |
132,785 |
| Excess tax benefits from stock-based awards |
32,891 |
57,101 |
22,166 |
| Purchase of noncontrolling Interests |
(67,947) |
(4,891) |
(3,843) |
| Purchases of marketable debt securities |
|
(53,952) |
(203,970) |
| Funds transferred to escrow for Meetic tender offer |
(71,512) |
|
|
| Debt issuance Costs |
(7,399) |
(11,001) |
|
| Intercompany |
0 |
0 |
0 |
| Other, net |
(3,787) |
244 |
(4,908) |
| Net cash provided by (used in) financing activities attributable to continuing operations |
17,922 |
44,301 |
(372,233) |
| Total cash used in continuing operations |
348,866 |
46,740 |
(25,033) |
| Total cash used in discontinued operations |
(1,877) |
(3,472) |
(8,417) |
| Effect of exchange rate changes on cash and cash equivalents |
3,478 |
2,556 |
(4,496) |
| Net increase (decrease) in cash and cash equivalents |
350,467 |
45,824 |
(37,946) |
| Cash and cash equivalents at beginning of period |
749,977 |
704,153 |
742,099 |
| Cash and cash equivalents at end of period |
$ 1,100,444 |
$ 749,977 |
$ 704,153 |